TapewireFind a company

person · Reporting owner

August Raymond Alexander

Disclosed activity across 2 companies

Tapewire entity
36818
SEC CIK
0001616278

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Benefitfocus, Inc.BNFT · Entity 12008Director · President and CEOMay 01, 2020May 05, 2020
DXC Technology CoDXC · Entity 4594President, Insurance SW & SvcsJune 16, 2026June 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Benefitfocus, Inc.

Report date May 01, 2020 · Filed May 05, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect644,811 Reported balance After 2020-05-01 transaction · row 1
1 source row

Row 1 · 2020-05-01 · Grant · Acquired 131,204 · Balance 644,811

F1: Represents restricted stock units which vest in three equal annual installments beginning on May 1, 2021, subject to continued employment.

Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2021-05-01Direct26,240 Reported balance After 2020-05-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-05-01 · Grant · Acquired 26,240 · Balance 26,240

F2: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2020 through December 31, 2020. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-05-01Direct196,806 Reported balance After 2020-05-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2020-05-01 · Grant · Acquired 196,806 · Balance 196,806

F3: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of software service revenue and adjusted EBITDA goals during the period of January 1, 2020 through December 31, 2020, such vesting to occur in three equal annual installments beginning on May 1, 2021, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units which vest in three equal annual installments beginning on May 1, 2021, subject to continued employment.

F2: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2020 through December 31, 2020. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F3: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of software service revenue and adjusted EBITDA goals during the period of January 1, 2020 through December 31, 2020, such vesting to occur in three equal annual installments beginning on May 1, 2021, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

DXC Technology Co

Report date June 16, 2026 · Filed June 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect394,562 Reported balance After 2026-06-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-16 · Tax withholding · Disposed 21,596 · Balance 394,562

F1: Shares withheld to satisfy tax liabilities arising from 47,619 restricted stock units (RSUs) that vested on June 16, 2026.

F2: Amount reported includes unvested RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld to satisfy tax liabilities arising from 47,619 restricted stock units (RSUs) that vested on June 16, 2026.

F2: Amount reported includes unvested RSUs.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2026 Filed Jun 18, 2026 20:43 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 21,596 $9.23 $199,331.08
Disclosure

SEC source: 0001688568-26-000054 · wk-form4_1781815431.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 394,562

F1 · shares: Shares withheld to satisfy tax liabilities arising from 47,619 restricted stock units (RSUs) that vested on June 16, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:39 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 9,270 $8.81 $81,668.70
Disclosure

SEC source: 0001688568-26-000053 · wk-form4_1781642379.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,158

F1 · shares: Shares withheld to satisfy tax liabilities arising from 20,441 restricted stock units (RSUs) that vested on June 15, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
May 22, 2026 Filed May 26, 2026 20:41 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 4,416 $9.50 $41,952.00
Disclosure

SEC source: 0001688568-26-000045 · wk-form4_1779828079.xml · nonDerivative · entry 2

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,428

F3 · shares: Shares withheld to satisfy tax liabilities arising from 9,736 restricted stock units (RSUs) that vested on May 22, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:41 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 8,849 $9.23 $81,676.27
Disclosure

SEC source: 0001688568-26-000045 · wk-form4_1779828079.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,844

F1 · shares: Shares withheld to satisfy tax liabilities arising from 19,511 restricted stock units (RSUs) that vested on May 21, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
May 15, 2026 Filed May 19, 2026 21:55 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 11,406 $8.94 $101,969.64
Disclosure

SEC source: 0001688568-26-000035 · wk-form4_1779227708.xml · nonDerivative · entry 2

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,693

F3 · shares: Shares withheld to satisfy tax liabilities arising from 25,150 restricted stock units (RSUs) that vested on May 15, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
May 15, 2026 Filed May 19, 2026 21:55 UTC DXC Technology Co DXC · Entity 4594 Tax withholdingCommon Stock 19,870 $8.94 $177,637.80
Disclosure

SEC source: 0001688568-26-000035 · wk-form4_1779227708.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,099

F1 · shares: Shares withheld to satisfy tax liabilities arising from 43,814 FY2024 performance-vesting restricted stock units that settled on May 15, 2026.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:46 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 98,023 $0.00 $0.00
Disclosure

SEC source: 0001688568-26-000025 · wk-form4_1778795176.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & Svcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 469,969

F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest in three equal annual installments beginning May 12, 2027.

F2 · balance_after: Amount reported includes unvested RSUs.

Read SEC document
April 29, 2026 Filed May 1, 2026 21:28 UTC DXC Technology Co DXC · Entity 4594 GrantCommon Stock 43,814 $0.00 $0.00
Disclosure

SEC source: 0001688568-26-000009 · wk-form4_1777670920.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President, Insurance SW & BPS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,946

F1 · shares: Award of regular-cycle FY2024 performance-vesting restricted stock units (PSUs) earned based on performance metrics measured over a three-year performance period. The PSUs will settle on or around May 23, 2026.

F2 · balance_after: Amount reported includes unvested restricted stock units.

Read SEC document
May 01, 2020 Filed May 5, 2020 19:31 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 196,806 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-027323 · doc4.xml · derivative · entry 3

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,806

Underlying: Common Stock · 196,806 shares

Expires 2023-05-01

F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of software service revenue and adjusted EBITDA goals during the period of January 1, 2020 through December 31, 2020, such vesting to occur in three equal annual installments beginning on May 1, 2021, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F3 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of software service revenue and adjusted EBITDA goals during the period of January 1, 2020 through December 31, 2020, such vesting to occur in three equal annual installments beginning on May 1, 2021, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
May 01, 2020 Filed May 5, 2020 19:31 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 26,240 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-027323 · doc4.xml · derivative · entry 2

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,240

Underlying: Common Stock · 26,240 shares

Expires 2021-05-01

F2 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2020 through December 31, 2020. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F2 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2020 through December 31, 2020. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
May 01, 2020 Filed May 5, 2020 19:31 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 131,204 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-027323 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 644,811

F1 · shares: Represents restricted stock units which vest in three equal annual installments beginning on May 1, 2021, subject to continued employment.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 17:03 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 74,733 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-023254 · doc4.xml · derivative · entry 4

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 74,733 shares

Expires 2023-04-01

F2 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F2 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 17:03 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 3,923 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-023254 · doc4.xml · derivative · entry 3

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,923 shares

Expires 2020-04-01

F2 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F2 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 17:03 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 1,682 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-023254 · doc4.xml · derivative · entry 2

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,923

Underlying: Common Stock · 1,682 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on April 1, 2019. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019.

F1 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on April 1, 2019. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 17:03 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 1,682 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-023254 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 513,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on April 1, 2019. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019.

Read SEC document
May 13, 2019 Filed May 14, 2019 16:58 UTC Benefitfocus, Inc. BNFT · Entity 12008 PurchaseCommon Stock 3,200 $31.15 $99,680.00
Disclosure

SEC source: 0001209191-19-029692 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 511,925

F1 · price: This transaction was executed in multiple trades at prices ranging from $31.05 to $31.16. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 74,733 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 11

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,733

Underlying: Common Stock · 74,733 shares

Expires 2023-04-01

F8 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of net annual recurring revenue bookings growth goals during the period of January 1, 2019 through December 31, 2019, such vesting to occur in four equal annual installments beginning on April 1, 2020, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F8 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of net annual recurring revenue bookings growth goals during the period of January 1, 2019 through December 31, 2019, such vesting to occur in four equal annual installments beginning on April 1, 2020, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 5,605 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 10

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,605

Underlying: Common Stock · 5,605 shares

Expires 2020-04-01

F7 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F7 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal and an adjusted EBITDA goal, during the period of January 1, 2019 through December 31, 2019. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 21,100 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 9

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,100 shares

Expires 2022-04-01

F6 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F6 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 79,611 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 8

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,100

Underlying: Common Stock · 79,611 shares

Expires 2022-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2018 through December 31, 2018. One-fourth of the shares are vested, with the remaining shares to vest in three equal annual installments beginning on April 1, 2020.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2018 through December 31, 2018. One-fourth of the shares are vested, with the remaining shares to vest in three equal annual installments beginning on April 1, 2020.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 929 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 7

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 929 shares

Expires 2019-04-01

F6 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F6 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 9,092 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · derivative · entry 6

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 929

Underlying: Common Stock · 9,092 shares

Expires 2019-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goal, an adjusted EBITDA goal, and a net new bookings goal, during the period of January 1, 2018 through December 31, 2018.

F1 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goal, an adjusted EBITDA goal, and a net new bookings goal, during the period of January 1, 2018 through December 31, 2018.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · nonDerivative · entry 5

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508,725

F5 · shares: Represents restricted stock units which will vest in full on April 1, 2023, subject to continued employment.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 24,911 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · nonDerivative · entry 4

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 458,725

F4 · shares: Represents restricted stock units which vest in four equal annual installments beginning on April 1, 2020, subject to continued employment.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 5,642 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · nonDerivative · entry 3

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 433,814

F3 · shares: Represents common stock of the Issuer resulting from the vesting of restricted stock units granted in connection with the achievement of performance metrics in 2018.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 79,611 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · nonDerivative · entry 2

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,172

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2018 through December 31, 2018. One-fourth of the shares are vested, with the remaining shares to vest in three equal annual installments beginning on April 1, 2020.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 9,092 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-023549 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on March 29, 2018. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goal, an adjusted EBITDA goal, and a net new bookings goal, during the period of January 1, 2018 through December 31, 2018.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 100,711 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 10

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,711

Underlying: Common Stock · 100,711 shares

Expires 2022-04-01

F6 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2018 through December 31, 2018, such vesting to occur in four equal annual installments beginning on April 1, 2019, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F6 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2018 through December 31, 2018, such vesting to occur in four equal annual installments beginning on April 1, 2019, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting will also accelerate as to the next tranche of vesting units in the event of death or disability after the performance period. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 10,021 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 9

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,021

Underlying: Common Stock · 10,021 shares

Expires 2019-04-01

F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal, an adjusted EBITDA goal, and a net new bookings goal, during the period of January 1, 2018 through December 31, 2018. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F5 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of an annual revenue goal, an adjusted EBITDA goal, and a net new bookings goal, during the period of January 1, 2018 through December 31, 2018. Vesting of the target level PRSUs will accelerate upon death or disability during the performance period in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 27,270 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 8

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,270 shares

Expires 2021-04-01

F4 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F4 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 6,363 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 7

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,363 shares

Expires 2018-04-01

F4 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F4 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 2,727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 6

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,363

Underlying: Common Stock · 2,727 shares

Expires 2018-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 31, 2017. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017.

F2 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 31, 2017. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 16,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 5

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,000 shares

Expires 2017-12-31

F4 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F4 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 24,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · derivative · entry 4

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 24,000 shares

Expires 2017-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on November 6, 2015. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of adjusted EBITDA and compounded annual revenue growth rate goals during the period of January 1, 2015 through December 31, 2017.

F1 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on November 6, 2015. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of adjusted EBITDA and compounded annual revenue growth rate goals during the period of January 1, 2015 through December 31, 2017.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 33,069 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · nonDerivative · entry 3

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,469

F3 · shares: Represents restricted stock units which vest in four equal annual installments beginning on April 1, 2019, subject to continued employment.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 2,727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · nonDerivative · entry 2

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Shares earned upon the vesting of a percentage of the PRSUs granted to the Reporting Person on March 31, 2017. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 18:10 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022563 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned upon the vesting of a percentage of the performance restricted stock units ("PRSUs") granted to the Reporting Person on November 6, 2015. Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of adjusted EBITDA and compounded annual revenue growth rate goals during the period of January 1, 2015 through December 31, 2017.

Read SEC document
December 31, 2017 Filed Jan 2, 2018 17:06 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 56,169 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-000280 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,673

F1 · shares: Represents restricted stock units which vest in five equal annual installments beginning on December 31, 2018, subject to continued employment.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 17:05 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 27,270 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-025030 · doc4.xml · derivative · entry 3

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,270

Underlying: Common Stock · 27,270 shares

Expires 2021-04-01

F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2017 through December 31, 2017, such vesting to occur in four equal annual installments beginning on April 1, 2018, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F3 · derivative.exercise_date: Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2017 through December 31, 2017, such vesting to occur in four equal annual installments beginning on April 1, 2018, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 17:05 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantPerformance Restricted Stock Units · Derivative 9,090 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-025030 · doc4.xml · derivative · entry 2

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,090

Underlying: Common Stock · 9,090 shares

Expires 2018-04-01

F2 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

F2 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 17:05 UTC Benefitfocus, Inc. BNFT · Entity 12008 GrantCommon Stock 18,180 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-025030 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,504

F1 · shares: Represents restricted stock units which vest in four equal annual installments beginning on April 1, 2018, subject to continued employment.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 17:25 UTC Benefitfocus, Inc. BNFT · Entity 12008 Disposition to issuerPerformance Restricted Stock Units · Derivative 449 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-016015 · doc4.xml · derivative · entry 3

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 449 shares

Expires 2016-12-31

F2 · derivative.exercise_price: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

F2 · derivative.exercise_date: Represents the portion of PRSUs that were forfeited to the Issuer after determining the percentage of PRSUs that vested.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 17:25 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionPerformance Restricted Stock Units · Derivative 7,222 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-016015 · doc4.xml · derivative · entry 2

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 449

Underlying: Common Stock · 7,222 shares

Expires 2016-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares earned upon the vesting of a percentage of the performance restricted stock units granted to the Reporting Person on March 30, 2016 ("PRSUs"). Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and non-GAAP net income (loss) goals during the period of January 1, 2016 through December 31, 2016.

F1 · derivative.exercise_date: Shares earned upon the vesting of a percentage of the performance restricted stock units granted to the Reporting Person on March 30, 2016 ("PRSUs"). Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and non-GAAP net income (loss) goals during the period of January 1, 2016 through December 31, 2016.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 17:25 UTC Benefitfocus, Inc. BNFT · Entity 12008 Exercise / conversionCommon Stock 7,222 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-016015 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned upon the vesting of a percentage of the performance restricted stock units granted to the Reporting Person on March 30, 2016 ("PRSUs"). Each PRSU represented a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of annual revenue goals and non-GAAP net income (loss) goals during the period of January 1, 2016 through December 31, 2016.

Read SEC document
October 03, 2016 Filed Oct 5, 2016 17:43 UTC Benefitfocus, Inc. BNFT · Entity 12008 SaleCommon Stock 16,408 $39.66 $650,741.28
Disclosure

SEC source: 0001209191-16-145088 · doc4.xml · nonDerivative · entry 1

August Raymond Alexander · CIK 0001616278 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,102

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2016 to satisfy the reporting person's tax withholding obligation upon scheduled vesting of restricted stock units granted on October 1, 2014.

F2 · price: This transaction was executed in multiple trades at prices ranging from $39.23 to $39.98. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.